These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 22345687)
1. Pitavastatin demonstrates long-term efficacy, safety and tolerability in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia. Stender S; Budinski D; Hounslow N Eur J Prev Cardiol; 2013 Feb; 20(1):29-39. PubMed ID: 22345687 [TBL] [Abstract][Full Text] [Related]
2. Pitavastatin shows greater lipid-lowering efficacy over 12 weeks than pravastatin in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia. Stender S; Budinski D; Gosho M; Hounslow N Eur J Prev Cardiol; 2013 Feb; 20(1):40-53. PubMed ID: 22679249 [TBL] [Abstract][Full Text] [Related]
3. Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia. Ose L; Budinski D; Hounslow N; Arneson V Atherosclerosis; 2010 May; 210(1):202-8. PubMed ID: 20080236 [TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of pitavastatin versus simvastatin. Eriksson M; Budinski D; Hounslow N Adv Ther; 2011 Sep; 28(9):799-810. PubMed ID: 21874537 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia. Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077 [TBL] [Abstract][Full Text] [Related]
6. Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia. Gumprecht J; Gosho M; Budinski D; Hounslow N Diabetes Obes Metab; 2011 Nov; 13(11):1047-55. PubMed ID: 21812889 [TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia. Sansanayudh N; Wongwiwatthananukit S; Putwai P; Dhumma-Upakorn R Ann Pharmacother; 2010 Mar; 44(3):415-23. PubMed ID: 20179259 [TBL] [Abstract][Full Text] [Related]
8. Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia. Ose L; Budinski D; Hounslow N; Arneson V Curr Med Res Opin; 2009 Nov; 25(11):2755-64. PubMed ID: 19785568 [TBL] [Abstract][Full Text] [Related]
9. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465 [TBL] [Abstract][Full Text] [Related]
10. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia. Park S; Kang HJ; Rim SJ; Ha JW; Oh BH; Chung N; Cho SY Clin Ther; 2005 Jul; 27(7):1074-82. PubMed ID: 16154486 [TBL] [Abstract][Full Text] [Related]
11. Pitavastatin - results from phase III & IV. Betteridge J Atheroscler Suppl; 2010 Dec; 11(3):8-14. PubMed ID: 21193153 [TBL] [Abstract][Full Text] [Related]
12. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin. da Silva PM Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial. Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317 [TBL] [Abstract][Full Text] [Related]
14. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study. Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245 [TBL] [Abstract][Full Text] [Related]
15. Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial. Aberg JA; Sponseller CA; Ward DJ; Kryzhanovski VA; Campbell SE; Thompson MA Lancet HIV; 2017 Jul; 4(7):e284-e294. PubMed ID: 28416195 [TBL] [Abstract][Full Text] [Related]
16. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies. Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175 [TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of pitavastatin and simvastatin in high-risk patients: a randomized controlled trial. Eriksson M; Budinski D; Hounslow N Adv Ther; 2011 Sep; 28(9):811-23. PubMed ID: 21874538 [TBL] [Abstract][Full Text] [Related]
19. One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response. Ferdinand KC; Davidson MH; Kelly MT; Setze CM Am J Cardiovasc Drugs; 2012 Apr; 12(2):117-25. PubMed ID: 22263674 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the lipid-lowering effects of pitavastatin 4 mg versus pravastatin 40 mg in adults with primary hyperlipidemia or mixed (combined) dyslipidemia: a Phase IV, prospective, US, multicenter, randomized, double-blind, superiority trial. Sponseller CA; Morgan RE; Kryzhanovski VA; Campbell SE; Davidson MH Clin Ther; 2014 Aug; 36(8):1211-22. PubMed ID: 24998014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]